Your session is about to expire
← Back to Search
Behavioral Activation for First Episode Psychosis
Study Summary
This trial will compare a behavioral intervention to usual care for people with first episode psychosis, delivered over 6 months. It is expected that those receiving the intervention will show better engagement.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I can speak English or Spanish.I have been diagnosed with a type of schizophrenia or related disorder.My psychosis is caused by another health issue or medication.I am between 15 and 35 years old.I have a serious health condition.I have been diagnosed with a type of schizophrenia or related disorder.You fully understand the study and agree to participate in it.You identify yourself as Latino.
- Group 1: Treatment at Usual
- Group 2: Behavioral Activation for First Episode Psychosis
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does this research endeavor accept participants aged 70 and above?
"This clinical trial is available to patients aged 15-35. For younger and older individuals, there are 118 trials for those under 18 years of age and 278 studies suitable for persons over the age of 65."
What is the ultimate aspiration of this research project?
"This medical study seeks to measure the Engagement of participants as evaluated by the Service Engagement Scale (SES) over a period, either 6 months after start or 12 sessions. There are three secondary objectives: assessing Change in Functioning with Strauss-Carpenter level of Function Scale (Strauss-Carpenter), measuring Recovery through Maryland Assessment of Recovery in People with SMI (MARS) at 6 month Post Intervention andChange in Symptoms using Positive And Negative Syndrome Scale (PANSS)."
Are there still slots open for participants in this research endeavor?
"According to information housed on clinicaltrials.gov, this medical trial is presently seeking participants and was first published in March of 2022. It underwent an update as recently as the 26th day of that same month."
Are there any prerequisites for enrollment in this research project?
"This trial seeks 58 participants aged between 15 and 35, who are Latino/a and able to understand English or Spanish. They must meet the Diagnostic & Statistical Manual of Mental Disorders-5 criteria for various diagnoses in the schizophrenia spectrum like schizoaffective disorder, schizophreniform disorder, brief psychotic disorder etc., while also having a caregiver willing to give informed consent."
How many participants are engaged in this clinical trial?
"Yes, according to clinicaltrials.gov the trial is currently accepting applications from patients. The original posting date was March 1st 2022 and it has recently been updated on March 26th 2022. 58 participants are required between two locations."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Share this study with friends
Copy Link
Messenger